GHB-induced delirium: a case report and review of the literature of gamma hydroxybutyric acid.
We describe what we believe is the first psychiatric hospitalization due to GHB-induced delirium reported in the medical literature. We examine the use of the substance gamma hydroxybutyric acid (GHB) and describe the clinical findings in a patient who presented to an acute inpatient psychiatric unit with a chief complaint of feeling suicidal and a 1-year history of GHB use. A review of the literature and GHB's availability through the Internet are discussed.
Hernandez
M
M
University of Southern California School of Medicine, Los Angeles, California, USA.
McDaniel
C H
CH
Costanza
C D
CD
Hernandez
O J
OJ
D000759:Adjuvants, Anesthesia / Q000009:adverse effects; D000328:Adult; D003693:Delirium / Q000139:chemically induced* / Q000175:diagnosis / Q000534:rehabilitation; D005260:Female; D006212:Hallucinations / Q000139:chemically induced / Q000175:diagnosis / Q000534:rehabilitation; D006801:Humans; D008609:Mental Status Schedule; D011605:Psychoses, Substance-Induced / Q000175:diagnosis / Q000523:psychology / Q000534:rehabilitation; D012978:Sodium Oxybate / Q000009:adverse effects; D013375:Substance Withdrawal Syndrome / Q000175:diagnosis / Q000523:psychology / Q000534:rehabilitation; D019966:Substance-Related Disorders / Q000175:diagnosis* / Q000523:psychology / Q000534:rehabilitation; D013405:Suicide / Q000523:psychology; D000092864:Suicide Prevention
D000759:Adjuvants, Anesthesia; D012978:Sodium Oxybate